In vitro ocular metabolism and bioactivation of ketoconazole in rat, rabbit and human.

[1]  Christine E. Dunne,et al.  Ocular Metabolism of Levobunolol: Historic and Emerging Metabolic Pathways , 2016, Drug Metabolism and Disposition.

[2]  U. Argikar,et al.  An in vitro approach to investigate ocular metabolism of a topical, selective β1-adrenergic blocking agent, betaxolol , 2015, Xenobiotica; the fate of foreign compounds in biological systems.

[3]  P. Thomas,et al.  Mycotic keratitis: epidemiology, diagnosis and management. , 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[4]  P. Asbell,et al.  Therapeutic Dilemmas in External Ocular Diseases , 1991, Drugs.

[5]  R. N. Brogden,et al.  Ketoconazole: A Review of its Therapeutic Efficacy in Superficial and Systemic Fungal Infections , 2012, Drugs.

[6]  U. Argikar,et al.  An experimental approach to enhance precursor ion fragmentation for metabolite identification studies: application of dual collision cells in an orbital trap. , 2011, Rapid communications in mass spectrometry : RCM.

[7]  L. P. Mašič.  Role of cyclic tertiary amine bioactivation to reactive iminium species: structure toxicity relationship. , 2011, Current drug metabolism.

[8]  U. Argikar,et al.  Identification of a Novel N-Carbamoyl Glucuronide: In Vitro, In Vivo, and Mechanistic Studies , 2010, Drug Metabolism and Disposition.

[9]  S. Kocsubé,et al.  Infectious Keratitis Caused by Aspergillus tubingensis , 2009, Cornea.

[10]  Yuan Chen,et al.  Revisiting the metabolism of ketoconazole using accurate mass. , 2009, Drug metabolism letters.

[11]  Huiyun Xia,et al.  Ocular pharmacokinetics of topically-applied ketoconazole solution containing hydroxypropyl beta-cyclodextrin to rabbits. , 2008, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[12]  N. Scheinfeld.  Ketoconazole: a review of a workhorse antifungal molecule with a focus on new foam and gel formulations. , 2008, Drugs of Today.

[13]  H. Yamazaki,et al.  Comparison of kinetic parameters for drug oxidation rates and substrate inhibition potential mediated by cytochrome P450 3A4 and 3A5. , 2008, Current drug metabolism.

[14]  P. Crooks,et al.  Phase I and phase II ocular metabolic activities and the role of metabolism in ophthalmic prodrug and codrug design and delivery. , 2007, Molecules.

[15]  R. Obach,et al.  METABOLISM OF NOMIFENSINE TO A DIHYDROISOQUINOLINIUM ION METABOLITE BY HUMAN MYELOPEROXIDASE, HEMOGLOBIN, MONOAMINE OXIDASE A, AND CYTOCHROME P450 ENZYMES , 2006, Drug Metabolism and Disposition.

[16]  R. Riley,et al.  Comparative analysis of substrate and inhibitor interactions with CYP3A4 and CYP3A5 , 2006, Xenobiotica; the fate of foreign compounds in biological systems.

[17]  Kayo Nakamura,et al.  Age, gender and region-specific differences in drug metabolising enzymes in rat ocular tissues. , 2005, Experimental eye research.

[18]  Li Liang,et al.  Cyanide trapping of iminium ion reactive intermediates followed by detection and structure identification using liquid chromatography-tandem mass spectrometry (LC-MS/MS). , 2005, Chemical research in toxicology.

[19]  Sapna Sharma,et al.  Clinical and experimental mycotic corneal ulcer caused by Aspergillus fumigatus and the effect of oral ketoconazole in the treatment , 1989, Mycopathologia.

[20]  E. Oji.  Study of ketoconazole toxiciy in rabbit cornea and conjuctiva , 1982, International Ophthalmology.

[21]  Darlene Miller,et al.  Advanced Fusarium Keratitis Progressing to Endophthalmitis , 2003, Cornea.

[22]  C. Miranda,et al.  Isoform specificity of N-deacetyl ketoconazole by human and rabbit flavin-containing monooxygenases. , 2000, Drug metabolism and disposition: the biological fate of chemicals.

[23]  D. Acosta,et al.  Metabolism of ketoconazole and deacetylated ketoconazole by rat hepatic microsomes and flavin-containing monooxygenases. , 1997, Drug metabolism and disposition: the biological fate of chemicals.

[24]  J. Zamecnik,et al.  Mouse hepatic metabolites of ketoconazole: isolation and structure elucidation. , 1994, Journal of pharmaceutical and biomedical analysis.

[25]  R. H. Rosa,et al.  The changing spectrum of fungal keratitis in south Florida. , 1994, Ophthalmology.

[26]  Fitzke Fw,et al.  The diagnosis of visual field progression in glaucoma. , 1994 .

[27]  L. Martínez,et al.  Topical ketoconazole for fungal keratitis. , 1985, American journal of ophthalmology-glaucoma.

[28]  J. Shock,et al.  Treatment of Aspergillus fumigatus keratitis in rabbits with oral and topical ketoconazole. , 1985, American journal of ophthalmology.

[29]  Y. Ishibashi.  Oral ketoconazole therapy for keratomycosis. , 1983, American journal of ophthalmology.

[30]  C. Foster,et al.  Ocular toxicity of topical antifungal agents. , 1981, Archives of ophthalmology.